Originally published In Press as doi:10.1074/jbc.M200212200 on March 29, 2002
J. Biol. Chem., Vol. 277, Issue 23, 20518-20526, June 7, 2002
Distinct Modes of Cell Death Induced by Different Reactive
Oxygen Species
AMINO ACYL CHLORAMINES MEDIATE HYPOCHLOROUS ACID-INDUCED
APOPTOSIS*
Robert P.
Englert
§ and
Emily
Shacter¶
From the
Department of Pediatrics, Uniformed Services
University of the Health Sciences, Bethesda, Maryland 20815 and
¶ Laboratory of Immunology, Division of Therapeutic Proteins,
Center for Biologics Evaluation and Research, Food and Drug
Administration, Bethesda, Maryland 20892
Received for publication, January 8, 2002, and in revised form, March 11, 2002
 |
ABSTRACT |
Oxidants derived from inflammatory phagocytes
compose a key element of the host immune defense system and can kill
mammalian cells by one of several different mechanisms. In this report, we compare mechanisms of cell death induced in human B lymphoma cells
by the inflammatory oxidants superoxide,
H2O2, and HOCl. The results indicate that
the mode of cell death induced depends on the nature of the oxidant
involved and the medium in which the cells are treated. When human
Burkitt's lymphoma cells are exposed to superoxide anion, generated as
a flux from xanthine and xanthine oxidase, the cells die by a
non-apoptotic mechanism (pyknosis/necrosis) identical to that seen when
cells are treated with a bolus of reagent
H2O2. Addition of superoxide dismutase has no
effect, whereas catalase is completely protective, indicating that
exogenously generated superoxide kills cells entirely through its
dismutation into H2O2. In contrast, cells
treated in culture media with reagent HOCl die largely by apoptosis.
HOCl-induced apoptosis is mediated by aminoacyl chloramines generated
in the culture media and can be mimicked by treatment of cells with
taurine chloramine or with long lived chloramines generated from
modified Lys or Arg. The results suggest that in a physiological milieu in which O
and
H2O2 are the main oxidants being formed, the
principal form of cell death may be necrotic, and under inflammatory
conditions in which HOCl is generated, apoptotic cell death may predominate.
 |
INTRODUCTION |
Oxidants (reactive oxygen species,
ROS)1 are generated in high
levels by activated phagocytes (neutrophils, monocytes, and macrophages) in inflammatory tissues (1, 2). These oxidants compose an
important element of the host defense against bacteria and tumor cells
(3). However, secreted ROS can have detrimental side effects as well,
causing tissue damage and contributing to the development or
progression of numerous different diseases (4). The primary oxidants
generated by all normal phagocytes are the superoxide anion
(O
) and hydrogen peroxide
(H2O2), which can, in the presence of reducing
metals, go on to form hydroxyl and other free radicals. In addition,
monocytes and neutrophils contain high levels of the enzyme
myeloperoxidase which catalyzes formation of the potent oxidant,
hypochlorous acid (HOCl). HOCl can then go on to react with
extracellular amino acids to generate chloramines, which maintain some
of the oxidizing potential of HOCl but are not as potent or as broadly
reactive (5-7). Each of these different ROS have molecular
characteristics that account for their different levels of reactivity
with cellular and extracellular macromolecules.
The studies presented here focus on mechanisms of cell death induced by
inflammatory oxidants. Mammalian cells can die by one of several
different defined pathways, the most common of which are apoptosis and
necrosis. Apoptosis is characterized by a discrete set of
biochemical steps and morphological changes including activation of
caspases, translocation of phosphatidylserine from the inner to the
outer layer of the plasma membrane, chromatin condensation, and
fragmentation into apoptotic bodies (8, 9). In contrast, cells that die
by necrosis swell and then lyse, releasing their contents into the
extracellular space (10). It is thought that death by apoptosis is
physiologically advantageous because early apoptotic cells are cleared
by phagocytosis and subsequent intracellular degradation (11). In this
manner, apoptotic cells are removed without causing damage to the
surrounding tissue. In contrast, necrotic cells are thought to promote
an inflammatory response caused by the leakage of intracellular
proteins and nucleic acids prior to phagocytosis. In support of this
theory, we found that B lymphoma cells treated with
H2O2 die by a non-apoptotic mechanism and are
not phagocytosed by macrophages until after they begin to lose their
plasma membrane integrity (12). In contrast, early apoptotic cells
induced by chemotherapy drugs underwent phagocytosis while their
membranes were still intact.
Previous research (13-21) has demonstrated that exogenously added
H2O2 can induce either apoptosis or necrosis,
depending on the concentration of H2O2, the
cell type being studied, and the level of ATP in the cells. Relatively
little has been reported on mechanisms of induction of cell death from
exogenously generated O
or HOCl (22),
such as would be produced by activated neutrophils, and we are unaware
of any study that does a direct comparison of the modes of cell death
induced by the different oxidants in the same cell type. This report
compares mechanisms of B lymphoma cell death induced by exogenous
O
, H2O2, and
HOCl. The data reveal that O
kills
cells solely through its dismutation into H2O2,
and both of these ROS kill by a non-apoptotic mechanism referred to as pyknosis/necrosis (20). In stark contrast, HOCl induces either necrosis
or apoptosis depending on the cell environment; in buffered saline,
cell death is entirely by rapid necrosis, and in growth media, cell
death is primarily apoptotic. We demonstrate further that long lived
aminoacyl chloramines mediate HOCl-induced apoptosis.
 |
MATERIALS AND METHODS |
Cells and Treatments--
The Burkitt's lymphoma cell lines
JLP-119 and BL-41 were grown in RPMI 1640 medium containing 10%
heat-inactivated fetal calf serum, 2 mM L-Gln,
and 50 µM
-mercaptoethanol at 37 °C in 5% CO2 in air as described previously (15). Exponentially
growing cells were harvested by centrifugation and resuspended in fresh media to achieve a culture density of 5 × 105
cells/ml. Reagent H2O2 (50-200
µM) was added to the cell suspensions, and the cells were
incubated at 37 °C for the times indicated in the figure legends. A
flux of O
and
H2O2 was generated by adding xanthine (XA,
50-400 µM) to the cells in culture media 1 h prior
to addition of xanthine oxidase (XO, 20 milliunits; Sigma catalog
number X-4500), and cells were incubated for the times indicated in the
figure legends. Reagent NaOCl (1-500 µM; Aldrich) or
H2O2 was added to the cell suspensions, and the
cells were incubated for the times indicated in the figure legends.
Concentrations of stock reagents were based on molar extinction
coefficients of 350 M
1 cm
1 for
NaOCl at 292 nm (23) and of 50 M
1
cm
1 for H2O2 at 240 nm (24).
Chloramine toxicity studies were carried out by mixing each amino acid
(2 mM in PBS on ice) with NaOCl (50-500 µM)
and then adding the mixtures (1 ml) immediately (<30 s) to cell
pellets to get a final density of 5 × 105 cells/ml.
After a 1-h incubation at 37 °C, 1 ml of complete media was added to
each well, and cells were incubated for an additional 7 h.
Morphological Assessment of Cell Death Using Hoechst/Propidium
(PI) Nuclear Staining and Fluorescence Microscopy--
Cells (5 × 105 cells/ml) were incubated for 15 min at 37 °C with
Hoechst 33342 dye (5 µg/ml in PBS), centrifuged, washed once in PBS,
and then resuspended at ~2.5 × 107 cells/ml.
Propidium iodide (PI; 50 µg/ml from a 1 mg/ml stock in PBS) was added
just before microscopy. Cells were visualized using fluorescence
microscopy as described previously (20). A minimum of 200 cells was
counted, and cell morphology was classified as follows: (i) live cells
(normal nuclei, blue chromatin with organized structure); (ii)
membrane-intact apoptotic cells (bright blue chromatin which is highly
condensed, marginated, or fragmented); (iii) membrane-permeable
apoptotic cells (bright red chromatin, highly condensed or fragmented);
(iv) necrotic cells (red, enlarged nuclei with smooth normal
structure); and (v) pyknotic/necrotic cells (dense, red, slightly
condensed nuclei with no fragmentation).
Assessment of Apoptosis Using FACScan Analysis--
To determine
the percentage of cells expressing phosphatidylserine (PS) on the
exofacial surface of the plasma membrane, cells were centrifuged and
resuspended in FACS buffer containing 1.25 µg/ml annexin V-FITC
(PharMingen) and 0.1 mg/ml PI in 140 mM NaCl, 2.5 mM CaCl2, 10 mM HEPES, pH 7.4, and
incubated for 15 min at room temperature. Cells (10,000 per sample)
were then analyzed on a FACScan (BD Biosciences) using the CELLQUEST
flow cytometric analysis software. Cells in the lower right dot plot
quadrant (PS-positive and PI-negative) were reported as apoptotic and
have intact plasma membranes, whereas cells in the upper right dot plot
quadrant (PS-positive and PI-positive) were scored as necrotic and have
leaky membranes. In theory, cells in this latter quadrant can also be
late apoptotic but were confirmed to be necrotic in our experiments
using fluorescence microscopy as described above. In control
experiments, we found that the annexin V FACS assay gave comparable
results to those obtained by fluorescence microscopy using
Hoechst/PI.
Western Blot Analysis for Apoptosis--
Cells were harvested by
centrifugation, washed twice with PBS, resuspended in lysis buffer
containing 62.5 mM Tris, pH 6.8, 2% SDS, 10% glycerol,
and 1 mM diethylenetriaminepentaacetic acid, and heated for
10 min at 100 °C. The total cell lysates (50 µg/lane) were
subjected to SDS-PAGE (25), transferred to nitrocellulose membranes,
blocked with 5% milk, and incubated with mouse monoclonal anti-human
CPP32 (caspase-3) followed by horseradish peroxidase-conjugated secondary antibody as described previously (21). Bands were visualized
by chemiluminescence using the ECL kit from PerkinElmer Life Sciences.
ATP Assay--
Intracellular ATP levels were determined using
luciferin-luciferase (26) as described previously (20, 21) with minor modifications. Briefly, cells (5 × 105 cells/ml) that
had been treated with H2O2 or HOCl were
collected by centrifugation, pelleted, lysed in 150 µl of 3%
HClO4, and placed on ice for 15 min. The solutions were
then neutralized with 75 µl of 1 M KOH and 30 µl
of potassium phosphate buffer (1 M
K2HPO4/KH2PO4, pH 7.4)
and incubated on ice for 15 min. The suspensions were centrifuged at
13,000 rpm for 1 min to remove the salt precipitate. Supernatants were
collected, diluted 1:5 with potassium phosphate buffer (10 mM KH2PO4, 4 mM
MgSO4, pH 7.4), and placed on ice. At the time of the
assay, 50-µl samples were mixed with 50 µl of 50 mM
NaAsO2, 20 mM MgSO4, pH 7.4, in a
96-well plate, followed by addition of 80 µg of luciferin/luciferase. Chemiluminescence was quantified in a Dynatech ML 3000 microtiter plate
luminometer (Chantilly, VA). ATP standard curves were run in all
experiments and were linear in the range of 5-2500 nM. Stock ATP concentrations were quantified from the absorbance at 259 nm
using a molar extinction coefficient of 15,400. ATP levels are reported
as the % of the ATP levels in control (untreated) cells.
GSH Assay--
The 5,5'-dithiobis(2-nitrobenzoic acid)
colorimetric assay (27) was used for the measurement of total cellular
non-protein thiols, which are predominantly GSH. Briefly, cells
(2-6 × 106 cells) treated with
H2O2 or HOCl were collected by centrifugation, washed once with PBS, and resuspended in 300 µl of a 2% solution of
5-sulfosalicylic acid for cell lysis and deproteinization. The samples
were centrifuged at 12,000 rpm for 5 min, and then 250 µl of sample
was mixed with 250 µl of 5,5'-dithiobis(2-nitrobenzoic acid) solution
(0.3 M sodium phosphate buffer, 10 mM EDTA, 0.2 mM 5,5'-dithiobis(2-nitrobenzoic acid), pH 8.0). After
incubation at room temperature for 5 min, the absorbance was read at
412 nm. Standard curves were run in all experiments and were linear in
the range of 5-100 µM glutathione. GSH levels are
reported as the percentage of the GSH levels in control (untreated) cells.
Chloramine Production and Decay Assay--
Solutions of
individual amino acids (2 mM in PBS) were mixed on ice with
50-500 µM HOCl. The absorbance at 252 nm was read immediately, and this value was used as the control (maximum) value
(23). The solutions were incubated at 37 °C to allow chloramine decay to occur, taking intermittent measurements of the residual absorbance at 252 nm. Results are reported as the percentage of control
value. All amino acids were purchased from Sigma except N-
-acetyl-Arg, which was from ICN.
Aldehyde Production Assay--
The 2,4-dinitrophenylhydrazine
colorimetric assay was used for measurement of aldehyde production as
described by Stadtman and Berlett (28). Stock solutions of amino acids
(2 mM in PBS) were mixed on ice with 500 µM
HOCl. The solutions were incubated at 37 °C to allow for decay of
the chloramines into aldehydes. At various time points, 100 µl of
sample was removed and added to 850 µl of 0.02%
2,4-dinitrophenylhydrazine in 2 M HCl and allowed to sit at
room temperature for 15 min. The solutions were neutralized by addition
of 750 µl of 2.5 M KOH and then centrifuged at 3,000 rpm
for 5 min. The absorbance of the supernatants at 540 nm was measured.
 |
RESULTS |
In previous studies, we found that the mode of B lymphoma cell
death induced by H2O2 is non-apoptotic (20). We
refer to the cell death induced by H2O2 in
these cells as pyknotic/necrotic because the nuclei are slightly
condensed, whereas there are no signs of classical apoptotic changes.
Quantification of H2O2-induced cell death (18 h
of incubation) in two different Burkitt's lymphoma (BL) cells lines is
shown in Fig. 1 and demonstrates again
that only a low level of apoptosis is induced by cytotoxic
concentrations of H2O2, which for these cell
lines is from 50 to 200 µM, with the BL-41 cell line
showing greater resistance to H2O2-induced cell
death (Fig. 1B) compared with JLP-119 cells (Fig.
1A). Because most H2O2 in
inflammatory conditions is derived from
O
, we set out to determine whether
exogenously generated O
causes a
similar or different mode of cell death. This question is of interest
because O
has the potential to
promote hydroxyl radical formation through the Haber-Weiss reaction, in
addition to forming H2O2. The results in Fig.
2 show that cell death induced by
exposure to O
generated from XO and
XA was primarily pyknotic/necrotic at all treatment levels, similar to
H2O2. Addition of superoxide dismutase to the
incubation medium had no effect on the type or level of cell death
induced, whereas catalase inhibited completely cell death induced by
XA/XO. Similar results were obtained with JLP-119 cells (data not
shown). The results show that cell death from exogenously generated
O
derives mostly from formation
of H2O2.

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 1.
Concentration-response study of cell death
induced by H2O2. JLP-119 cells
(A) and BL-41 cells (B) were treated with the
indicated concentrations of H2O2 in complete
media for 18 h at 37 °C, without washing or exchanging the
media, harvested, and stained with Hoechst/PI. Cell death was assessed
by nuclear morphology using fluorescence microscopy as described under
"Materials and Methods."
|
|

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 2.
Concentration-response study of cell death
induced by XA and XO. BL-41 cells were incubated with the
indicated concentrations of XA for 1 h prior to addition of XO (20 milliunits) in the presence or absence of superoxide dismutase
(SOD) or catalase in complete media. Cells were then
incubated for 18 h at 37 °C, without washing or exchanging the
media, harvested, and stained with Hoechst/PI. Cell death was assessed
by nuclear morphology using fluorescence microscopy as described under
"Materials and Methods."
|
|
One of the main oxidants generated during an inflammatory response
involving neutrophils and/or undifferentiated monocytes is HOCl, formed
from the action of myeloperoxidase on H2O2 and Cl
(2). When we exposed BL cells to reagent HOCl, we
found that, in stark contrast to H2O2 and
O
, a high level of apoptosis was
induced (Fig. 3). The other main form of
cell death induced from HOCl was classical necrosis, with only a low
level of pyknosis/necrosis seen (determined from the nuclear morphology). Note that BL-41 cells, which are somewhat more resistant to oxidant-induced killing than JLP-119 cells, incurred a higher level
of necrosis compared with JLP-119 cells, which were mostly apoptotic.
Apoptosis was confirmed by measuring activation of caspase-3, as
determined from cleavage of the caspase-3 pro-enzyme by Western blot
immunoassay (Fig. 4) and by measuring
annexin V binding to externalized PS (see below).

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 3.
Concentration-response study of cell death
induced by HOCl. JLP-119 cells (A) and BL-41 cells
(B) were treated with the indicated concentrations of HOCl
in complete media for 18 h at 37 °C, without washing or
exchanging the media, harvested, and stained with Hoechst/PI. Cell
death was assessed by nuclear morphology using fluorescence microscopy
as described under "Materials and Methods."
|
|

View larger version (9K):
[in this window]
[in a new window]
|
Fig. 4.
HOCl exposure induces caspase-3 cleavage in
both JLP-119 and BL-41 cells. JLP-119 and BL-41 cells were treated
with 500 µM HOCl for 10 h, without washing or
exchanging the media, and cell lysates were prepared as described under
"Materials and Methods." Caspase-3 cleavage was assessed by Western
blot immunoassay for the CPP32 (pro-caspase-3) protein.
|
|
To determine why H2O2 and HOCl induce such
different forms of cell death, we compared the effects of these two
oxidants on GSH and ATP levels in the cells. As shown in Fig.
5, the differences cannot be attributed
to different effects on cellular GSH levels. Concentrations of
H2O2 and HOCl that induce roughly 60-80% cell death in the cells caused mild to moderate reductions in cellular GSH
levels (
20% decrease in JLP-119 cells and
35% decrease in BL-41
cells), and the effects of H2O2 and HOCl were
nearly identical. In contrast, the effects of
H2O2 and HOCl on cellular ATP levels were
markedly different (Fig. 6). As we saw
previously (20), H2O2 caused a complete and
irreversible loss of intracellular ATP within 15 min after addition to
the cells. However, HOCl caused only a mild and transient drop in ATP
levels that was restored to control levels within 1 (BL-41 cells) to
2 h (JLP-119 cells). The ability of HOCl to induce apoptosis
correlates with its ability to induce significant cell damage without
depleting the cells of ATP and is consistent with reports that ATP must
be maintained at or above 25% of control levels in order for apoptosis
to occur (19-21, 29).

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 5.
GSH levels in Burkitt's lymphoma cells after
exposure to H2O2 or HOCl. JLP-119 cells
(A) and BL-41 cells (B) were exposed to
H2O2 (100 µM for JLP-119 or 200 µM for BL-41 cells) or HOCl (500 µM for
both cell lines) for up to 2 h, without washing or exchanging the
media. Cellular GSH levels were measured at the indicated times and are
presented as the percentage of the GSH levels in control (untreated)
cells. Control GSH levels in JLP-119 and BL-41 cells were 2 and 3 nmol/106 cells, respectively.
|
|

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 6.
ATP levels in Burkitt's lymphoma cells after
exposure to H2O2 or HOCl. JLP-119 cells
(A) and BL-41 cells (B) were exposed to
H2O2 (100 µM for JLP-119 or 200 µM for BL-41 cells) or HOCl (500 µM for
both cell lines) for up to 2 h, without washing or exchanging the
media. Cellular ATP levels were measured at the indicated times and are
presented as the percentage of the ATP levels in control (untreated)
cells. Control ATP levels in JLP-119 and BL-41 cells were 0.9 and 1.3 nmol/106 cells, respectively.
|
|
Previous studies into the mechanism of cytotoxicity induced by HOCl
found that the main mode of cell death is necrotic (30), with
endothelial cells undergoing only low levels of apoptosis in response
to HOCl treatment (22). We noted that those earlier studies were
carried out by treating the cells in buffer, not growth media, so we
set out to determine whether the medium in which the cells are treated
influences the mechanism of cell killing. Note that these and all
subsequent experiments were performed with BL-41 cells, and apoptosis
was quantified primarily by measuring binding of annexin V followed by
FACS analysis to detect cells that have externalized plasma membrane
phosphatidylserine, a hallmark of apoptosis. BL-41 cells were selected
because they express significantly higher levels of exofacial PS than
JLP-119 cells. Control studies showed that the annexin V assay gave
nearly identical results for the quantification of apoptotic and
necrotic cells as the assay for nuclear morphology (see "Materials
and Methods" for experimental details). The results in Fig.
7 show that when BL-41 cells are treated
with HOCl in PBS/glucose, cell death is entirely by necrosis. In
contrast, when the cells are treated either in complete media
(i.e. containing 10% fetal calf serum) or in RPMI alone, cell death is primarily apoptotic. The data in Fig. 7 also demonstrate that higher levels of HOCl are required to kill the cells
in the more complex media, i.e. cell death measured at 8-10 h is only 70% as high when the cells are treated in complete media (RPMI plus 10% serum) than when they are treated in plain RPMI. Significantly higher cell death is achieved at lower HOCl
concentrations when the cells are treated in PBS/glucose, and death
appears much more rapidly (within 2 h).

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 7.
HOCl induces different levels and modes of
cell death depending on the medium in which the cells are treated.
BL-41 cells were treated with the indicated concentrations of HOCl in
either PBS/glucose, RPMI, or complete media (RPMI + 10% fetal calf
serum (FCS)) for the times indicated. Cell death was
assessed by flow cytometry following staining with FITC-annexin V and
PI (see inset for sample data). Cell death is reported as
either necrotic (black bars, upper right quadrant
in FACS analysis) or apoptotic (striped bars; lower
right quadrant in FACS analysis) as described under "Materials
and Methods." Cells in the upper right quadrant were
confirmed to be necrotic and not late apoptotic by fluorescence
microscopy. The data presented represent averages from 2 to 3 separate
experiments carried out in duplicate.
|
|
It is widely thought that oxidants and other cytotoxic agents induce
apoptosis at low concentrations and necrosis at high concentrations
(13). To determine whether HOCl might induce apoptosis in PBS if lower
concentrations were employed, we treated BL-41 cells with levels of
HOCl ranging from 1 to 500 µM, and we measured cell death
after 8 h. The cells are relatively unstable in PBS/glucose in the
absence of protein and die spontaneously when incubated for longer
times. Hence, incubations in PBS were limited to 2 h after which
complete media were added, and the cells were incubated for an
additional 6 h. As shown in Fig. 8, we did not detect any apoptosis when cells were treated in this manner
with low concentrations of HOCl in PBS/glucose.

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 8.
Concentration-response study of cell death
induced by HOCl in PBS. BL-41 cells were exposed to the indicated
concentrations of HOCl in PBS. At 2 h complete medium was added,
and cells were incubated for an additional 6 h. Cell death was
assessed by flow cytometry and reported as either necrotic or apoptotic
as described in the legend to Fig. 7.
|
|
The results in Fig. 7 demonstrate a profound effect of the media on the
mode and level of cell killing by HOCl. RPMI contains several types of
components including vitamins, salts, glucose, and high levels of free
amino acids (6.8 mM total, which is comparable with the
level of amino acids found in human plasma) (31). In initial
experiments, we found that of these components, only the amino acids
influenced HOCl-induced cell killing; treatment of cells in RPMI
vitamins or salts gave results similar to treatment in PBS/glucose. It
is well known that HOCl can react with amino acids to form chloramines
(5-7) and that these can be cytotoxic (32). The mode of cell killing
by aminoacyl chloramines has not been described previously. The
following experiments demonstrate that induction of apoptosis by
treatment of BL cells with HOCl in RPMI is mediated by formation of
long lived aminoacyl chloramines. Unless otherwise noted, the
experiments employed 500 µM HOCl, which causes 40-60%
apoptotic cell death when cells are treated in RPMI.
First, spectrophotometric studies showed that when different amino
acids (2 mM) were incubated with HOCl (500 µM) on ice, they were converted immediately (within
seconds) to chloramines, which have a characteristic absorbance peak at
252 nm as described by Test et al. (6) (data not shown). At
the same time, the absorbance peak for reagent HOCl at 292 nm was lost
immediately. At this ratio of amino acids to HOCl (4:1), there was no
detectable HOCl remaining after it was added to the amino acid mixtures.
Chloramines have different levels of stability depending on the
chemistry of the modified amino group. The data in Fig.
9A show that most of the
aminoacyl chloramines tested were short lived and decomposed in the
course of a 30-min incubation at room temperature. These short lived
chloramines are known to be derived from reaction of the
-amino
group with HOCl (5, 33, 34). In contrast, the chloramine formed from
the
-amino acid taurine was stable, as expected (23), and did not
decompose into an aldehyde even after an overnight incubation (data not
shown). The results with Lys and Arg were mixed because they have
additional amino groups that can react with HOCl to form chloramines of
differing stability. As shown in Fig. 9A, when the
-amino
group of Lys was blocked by N-acetylation, a stable
chloramine was formed on the
-amino group. However, when the
-amino group was blocked, an unstable
-chloramine was formed that
decomposed into an aldehyde (Fig. 9B). The finding that
non-acetylated Lys decayed by more than 50% is consistent with the
finding of Hazen et al. (33) that the
-amino group is
more susceptible to chlorination than the
-amino group. A similar
result was obtained with Arg; when the
-amino group was blocked with
an acetyl moiety, a stable chloramine was formed, whereas when the side
chain guanidium group was blocked, a relatively labile chloramine was
formed. Note also that the rates of decay of the different
-chloramines are not uniform; Glu and Gln decayed extremely rapidly,
whereas Ile and His decayed more slowly. Formation of aldehydes from
each of the amino acids that showed chloramine decay, as shown for
N-
-acetyl-Lys in Fig. 9B and as characterized
previously (33, 34), was confirmed as described under "Materials and
Methods" (data not shown).

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 9.
Generation of chloramines and aldehydes from
HOCl treatment of amino acids. A, amino acids (2 mM) were mixed with HOCl (500 µM) in PBS on
ice. Chloramine formation and decay was assessed from the absorbance at
252 nm during incubation at room temperature. The results are presented
as the percentage of absorbance at 252 nm at time 0. B,
aldehyde formation was measured as described under "Materials and
Methods" from the absorbance at 540 nm. Chloramine decay and aldehyde
formation for HOCl treated N- -acetyl-Lys are shown.
|
|
The results in Fig. 10 show the
different modes of cell death induced by treating BL-41 cells with the
different aminoacyl chloramines. For these experiments, each amino acid
(2 mM in PBS) was mixed on ice with HOCl (100-500
µM) and then added to cells in PBS/glucose. PBS/glucose
alone was used as the control. The cells were incubated for 1 h at
37 °C followed by addition of an equal volume of complete media and
incubation for an additional 7 h. The mode of cell death was
assessed by measuring PS externalization and permeability to propidium
iodide. The control treatment with PBS/glucose for 1 h followed by
incubation with media resulted in roughly 18% cell death, mostly by
necrosis. This level of cell death was subtracted from the treatment
groups in order to depict only the increase in cell death induced by
the various HOCl-modified amino acids. The results demonstrate that
treatment of the cells with three long lived chloramines (from taurine,
N-
-acetyl-Lys and N-
-acetyl-Arg) caused
cell death primarily through apoptosis. HOCl-modified Lys also caused
apoptosis but only when tested at lower concentrations (100 µM); at higher concentrations (up to 500 µM), the aldehydes and subsequent breakdown products from this amino acid caused increasing amounts of necrosis. Ile and His,
which formed chloramines with an intermediate half-life, induced cell
death that was roughly half-apoptotic and half-necrotic. The products
of HOCl plus Gln, Glu, and N-
-acetyl-Lys were relatively non-toxic. Control experiments showed no toxicity from free amino acids
(2 mM in PBS/glucose) that had not been reacted with HOCl. These included His, Leu, Ile, Lys, Glu, Gln, Arg, taurine,
N-
-acetyl-Lys, and complete mixtures of RPMI amino acids
(Sigma) tested 1 time (total amino acid concentration of 6.8 mM).

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 10.
Concentration-response study of cell death
induced by HOCl and chloramine (NCl) treatment.
BL-41 cells were exposed to either HOCl (500 µM) or
aminoacyl chloramines. After a 1-h incubation, an equal volume of
complete media was added, and the cells were incubated for an
additional 7 h at 37 °C. Cell death was assessed by flow
cytometry following staining with FITC-annexin V and PI and reported as
either necrotic or apoptotic as described under "Materials and
Methods." The levels of cell death shown reflect the increases over
control values. The data presented represent averages from 2-3
separate experiments carried out in duplicate.
|
|
 |
DISCUSSION |
In this report, we demonstrate two significant new findings as
follows: 1) different ROS induce different modes of cell death in human
B lymphoma cells, and 2) HOCl-induced apoptosis is mediated by the
interaction of HOCl with amino acids in the medium to form aminoacyl
chloramines. Exogenously generated O
kills cells entirely through its dismutation into
H2O2, and both O
and H2O2
kill lymphoma cells by a non-apoptotic mechanism referred to as
pyknosis/necrosis. As described previously for
H2O2, these cells have mildly condensed (pyknotic) nuclei but show none of the classical features of apoptosis such as externalization of PS, caspase activation, formation of apoptotic bodies, or DNA ladder formation (15, 20). In contrast, HOCl induces either necrosis or apoptosis depending on the medium in
which the cells are treated. When cells are treated with HOCl in
buffered saline, cell death is entirely by necrosis, and when cells are
treated with HOCl in complete media, significant apoptosis is observed.
These two findings will be discussed in greater detail below.
Induction of Different Modes of Cell Death by Different
ROS--
The term "oxidative stress" is a catch-all term intended
to describe the condition that exists when the levels of ROS produced exceed the capacity of anti-oxidant systems to remove those ROS such
that excess oxidants exist in a cell or tissue. The term is nondescript
regarding which ROS are involved. Our results indicate that the mode of
cell death induced by "oxidants" depends on the nature and
environment of the ROS that are involved, and this will depend on the
source of the oxidative stress. Note that because our research focuses
on how oxidants that are generated during inflammation induce cell
death in target tumor cells, the experiments described here examine the
effects of oxidants generated outside of a cell. The results cannot be
employed to deduce how these same oxidants might act if generated
inside of a cell, where different intracellular compartments would be
affected. Under biological conditions in which
O
and H2O2
are the main oxidants being formed, cell death in human B lymphoma cells is expected to be non-apoptotic, whereas if HOCl is the predominant oxidant, cell death may instead be by apoptosis. It should
be pointed out that, experimentally, H2O2 can
induce apoptosis, but this only occurs in cells where the ATP levels
are maintained above a certain threshold level of roughly 25% of
control ATP levels (19-21, 29). This may naturally be the case for
certain cell types such as T cells, which have been shown to undergo
apoptosis in response to H2O2 but can also be
induced experimentally in B lymphoma cells by inhibiting the activation
of poly(ADP-ribose) polymerase that follows
H2O2-induced strand breakage (20, 21, 35). In
fact, even high levels of H2O2 can induce
apoptosis as long as cellular ATP levels are maintained. Incidentally,
our studies also show that the same mode of cell death is induced by
H2O2 regardless of whether the cells are
exposed to a bolus (reagent) or flux (from XA/XO) of
H2O2. Physiological conditions in which
O
and H2O2
predominate would include conditions of ischemia-reperfusion such as
occur during a heart attack or ischemic stroke, following exposure to
ionizing radiation or redox active drugs and chemicals, and during
inflammatory conditions involving primarily macrophages. Due to the
high levels of myeloperoxidase in human neutrophils, a significant
portion of the H2O2 that is generated by these
cells is converted to HOCl (1, 23, 36, 37). Hence, physiological
conditions that lead to extensive HOCl formation will be acute and
chronic inflammatory conditions involving neutrophils and
monocytes (which also express myeloperoxidase).
Mechanism of HOCl-induced Cytotoxicity--
Most studies of
HOCl-induced cytotoxicity have been carried out on cells incubated in
buffer solutions instead of cell culture media (30, 38, 39). In these
studies, the mode of cell death was not specifically determined, but
cytotoxicity was assayed by methods that are generally reflective of
necrosis (e.g. trypan blue exclusion or Cr51
release). In more recent studies, Vissers et al. (22)
treated endothelial cells with HOCl for 15 min in buffered saline and then transferred the cells to complete media. Under these conditions, they found that at most 20% of the cells died by apoptosis and that
the predominant form of cell death induced by higher levels of HOCl was
by necrosis, consistent with our results. But in vivo, cells
will not be exposed to HOCl in the absence of a large number of
molecules that will react with the HOCl, primary among which are
proteins and free amino acids. Hence, we focused on the mechanisms of
cell death induced by HOCl in the presence of biological media.
The novel finding that we present here is that when cells are exposed
to HOCl in growth media, death is directed toward apoptosis instead of
necrosis, and this induction of apoptosis is due to the formation of
aminoacyl chloramines in the medium. HOCl-generated chloramines have
long been known to be cytotoxic both to bacteria and mammalian cells
(32, 38-44), but here, too, the mechanism of cell death either was not
studied or measured only loss of membrane integrity (release of
Cr51). Our results suggest that the mode of mammalian cell
death induced may have been apoptotic, but the cells were examined at
late time points, by which time the membranes had become leaky. In
fact, in many of these studies, taurine was found to protect cells from HOCl toxicity. Consistent with our results, the death from which the
cells were protected was HOCl-induced necrosis.
As pointed out by Weiss and colleagues (6, 45), long lived chloramines
differ significantly from HOCl because they maintain an oxidizing
potential yet are stable enough to diffuse some distance before
oxidizing susceptible target molecules. In vivo, the most abundant amino acid in cells and tissues is taurine (46, 47), which
forms a long lived chloramine that we now show causes apoptosis. Taurine is especially abundant in neutrophils, being present at ~20
mM (40, 48), and our data would predict that the main form
of neutrophil cell death should be apoptotic because much of the HOCl
is scavenged by taurine to form taurine chloramine (23, 45). This
prediction has been borne out by studies of Wagner et al.
(49) who showed that the cell death induced in myelomonocytic HL-60
cells by H2O2 is mediated by myeloperoxidase, and the mode of cell death is apoptotic. In addition, neutrophils are
known to secrete taurine into the extracellular medium (40), thereby
increasing the likelihood that neutrophil-induced death in
neighboring cells (e.g. target tumor cells) will be apoptotic.
We find that the short lived aminoacyl chloramines, which decay rapidly
into aldehydes and tertiary products (33, 34, 50, 51), can have
variable effects on cell viability. The chemical structures of 13 of
the aldehyde products have been characterized by mass spectrometry by
Heinecke and colleagues (33, 34, 51). Our data show that some aminoacyl
chloramines, such as from Glu and Leu, decay into aldehydes
(3-carboxy-propanal and 3-methyl-1-butanal, respectively) that
are relatively non-toxic to cells and protect them from HOCl toxicity,
allowing neither necrosis nor apoptosis. Others decay into highly
cytotoxic aldehydes that induce necrosis, as is seen from the
degradation of Ala monochloramine into acetaldehyde (data not shown).
Amino acids that form chloramines of intermediate half-life kill by
both apoptosis and necrosis, with the necrosis probably being induced
primarily by the aldehydes and/or tertiary products formed. Because all
of these amino acids are present in RPMI at varying concentrations,
they compete with each other for the limiting amounts of HOCl used in
these studies. The net effect is that treatment of cells in either RPMI
or complete media results in at least a substantial proportion of the
cells dying by apoptosis instead of necrosis. Serum proteins also react
with HOCl and in these studies appear to act as true scavengers,
protecting the cells from HOCl toxicity such that higher levels of HOCl
are required to induce cell death.
Future studies will examine the molecular targets and pathways that
account for chloramine-induced apoptosis in human lymphoma cells. Rapid
loss of membrane integrity (lysis) in cells treated with HOCl in PBS
(as evidenced by uptake of PI or release of Cr51 (30))
indicates that HOCl toxicity derives in part from a direct attack of
the oxidant on the cell membrane. HOCl is known to modify membrane
lipids (52-54) as well as protein and DNA. On the other hand,
aminoacyl chloramines are not as reactive as HOCl and hence are
expected to have a more selective spectrum of molecular targets. The
absence of lysis of cells treated with the long lived aminoacyl chloramines from taurine, N-
-acetyl-Lys, and
N-
-acetyl-Arg, even at concentrations of 500 µM, suggests that the chloramines may not act on membrane
lipids. Instead, proteins compose a likely target of chloramine
oxidation, with cysteine thiols and the methionine sulfoether being
most susceptible (55, 56). Taurine chloramine in particular has been
shown to modify and inhibit activities of various proteins (38,
56-58). The critical task for apoptosis research will be to identify
the specific molecular targets that initiate caspase activation and the
remainder of the apoptotic cascade.
 |
ACKNOWLEDGEMENTS |
We are grateful to Dr. Yang-Ja Lee for
careful reading of the manuscript and to Dr. Howard Anderson for
guidance with the FACS analyses and for many useful suggestions.
 |
FOOTNOTES |
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
Performed this work while training as a fellow in neonatology at
the Uniformed Services University of the Health Sciences.
To whom correspondence should be addressed: Center for
Biologics Evaluation and Research, Food and Drug Administration, Bldg. 29A, Rm. 2A-11, 29 Lincoln Dr., Bethesda, MD 20892. Tel.: 301-827-1833; Fax: 301-480-3256; E-mail: shacter@cber.fda.gov.
Published, JBC Papers in Press, March 29, 2002, DOI 10.1074/jbc.M200212200
 |
ABBREVIATIONS |
The abbreviations used are:
ROS, reactive oxygen
species;
XO, xanthine oxidase;
XA, xanthine;
PBS, phosphate-buffered
saline;
FACS, fluorescence-activated cell sorter;
PS, phosphatidylserine;
PI, propidium iodide;
FITC, fluorescein
isothiocyanate;
BL, Burkitt's lymphoma.
 |
REFERENCES |
| 1.
|
Klebanoff, S. J.
(1999)
in
Inflammation: Basic Principles and Clinical Correlates
(Gallin, J. I.
, and Snyderman, R., eds), 3rd Ed.
, pp. 721-768, Lippincott Williams & Wilkins, Philadelphia
|
| 2.
|
Babior, B. M.
(2000)
Am. J. Med.
109,
33-44[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Babior, B. M.
(1978)
Blood
298,
659-668
|
| 4.
|
Halliwell, B.,
and Gutteridge, J. M. C.
(1990)
Methods Enzymol.
186,
1-85[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Zgliczynski, J. M.,
Stelmaszynska, T.,
Ostrowski, W.,
Naskalski, J.,
and Sznajd, J.
(1968)
Eur. J. Biochem.
4,
540-547[Medline]
[Order article via Infotrieve]
|
| 6.
|
Test, S. T.,
Lampert, M. B.,
Ossana, P. J.,
Thoene, J. G.,
and Weiss, S. J.
(1989)
J. Clin. Invest.
74,
1341-1349
|
| 7.
|
Thomas, E. L.,
Grisham, M. B.,
and Jefferson, M. M.
(1983)
J. Clin. Invest.
72,
441-454[Medline]
[Order article via Infotrieve]
|
| 8.
|
Kerr, J. F. R.,
Wyllie, A. H.,
and Currie, A. R.
(1972)
Br. J. Cancer
26,
239-257[Medline]
[Order article via Infotrieve]
|
| 9.
|
Zimmermann, K. C.,
and Green, D. R.
(2001)
J. Allergy Clin. Immunol.
108,
99-103
|
| 10.
|
Wyllie, A. H.,
and Duvall, E.
(1992)
in
Oxford Textbook of Pathology
(McGee, J. O.
, Isaacson, P. J.
, and Wright, N. A., eds)
, pp. 141-157, Oxford University Press, Oxford
|
| 11.
|
Savill, J.,
and Fadok, V.
(2000)
Nature
407,
784-788[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Shacter, E.,
Williams, J. A.,
Hinson, R. M.,
Senturker, S.,
and Lee, Y. J.
(2000)
Blood
96,
307-313[Abstract/Free Full Text]
|
| 13.
|
Lennon, S. V.,
Martin, S. J.,
and Cotter, T. G.
(1991)
Cell Proliferation
24,
203-214[Medline]
[Order article via Infotrieve]
|
| 14.
|
Buttke, T. M.,
and Sandstrom, P. A.
(1994)
Immunol. Today
17,
7-10[Medline]
[Order article via Infotrieve]
|
| 15.
|
Lee, Y.-J.,
and Shacter, E.
(1997)
Blood
12,
4480-4492
|
| 16.
|
Gardner, A. M., Xu, F.-H.,
Fady, C.,
Jacoby, F. J.,
Duffy, D. C., Tu, Y.,
and Lightenstein, A.
(1997)
Free Radic. Biol. Med.
22,
73-83[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Hampton, M. B.,
and Orrenius, S.
(1997)
FEBS Lett.
414,
552-556[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
Palomba, L.,
Branbilla, L.,
Brandi, G.,
Sestili, P.,
Cattabeni, F.,
and Cantoni, O.
(1996)
Eur. J. Pharmacol.
318,
167-173[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Lelli, J. L.,
Becks, L. L.,
Dabroska, M. I.,
and Hinshaw, D. B.
(1998)
Free Radic. Biol. Med.
25,
694-702[CrossRef][Medline]
[Order article via Infotrieve]
|
| 20.
|
Lee, Y.-J.,
and Shacter, E.
(1999)
J. Biol. Chem.
274,
19792-19798[Abstract/Free Full Text]
|
| 21.
|
Lee, Y.,
and Shacter, E.
(2000)
Free Radic. Biol. Med.
29,
684-692[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Vissers, M. C.,
Pullar, J. M.,
and Hampton, M. B.
(1999)
Biochem. J.
344,
443-449
|
| 23.
|
Weiss, S. J.,
Klein, R.,
Slivka, A.,
and Wei, M.
(1982)
J. Clin. Invest.
70,
598-607[Medline]
[Order article via Infotrieve]
|
| 24.
|
Thurman, R. G.,
Ley, H. G.,
and Scholz, R.
(1972)
Eur. J. Biochem.
25,
420-430[Medline]
[Order article via Infotrieve]
|
| 25.
|
Laemmli, U. K.
(1970)
Nature
227,
680-685[CrossRef][Medline]
[Order article via Infotrieve]
|
| 26.
|
Spragg, R. G.,
Hinshaw, D. B.,
Hyslop, P. A.,
Schraufstätter, I. U.,
and Cochrane, C. G.
(1985)
J. Clin. Invest.
76,
1471-1476[Medline]
[Order article via Infotrieve]
|
| 27.
|
Tietze, T.
(1969)
Anal. Biochem.
27,
502-522[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
Stadtman, E. R.,
and Berlett, B. S.
(1991)
J. Biol. Chem.
266,
17201-17211[Abstract/Free Full Text]
|
| 29.
|
Eguchi, Y.,
Shimizu, S.,
and Tsujimoto, Y.
(1997)
Cancer Res.
57,
1835-1840[Abstract/Free Full Text]
|
| 30.
|
Schraufstätter, I. U.,
Browne, K.,
Harris, A.,
Hyslop, P. A.,
Jackson, J. H.,
Quehenberger, O.,
and Cochrane, C. G.
(1990)
J. Clin. Invest.
85,
554-562[Medline]
[Order article via Infotrieve]
|
| 31.
|
Linder, M.
(1992)
in
Nutritional Biochemistry and Metabolism
(Linder, M., ed)
, pp. 87-109, Elsevier Science Publishing Co., Inc., New York
|
| 32.
|
Thomas, E. L.,
Grisham, M. B.,
and Jefferson, M. M.
(1986)
Methods Enzymol.
132,
585-593[Medline]
[Order article via Infotrieve]
|
| 33.
|
Hazen, S. L.,
Hsu, F. F.,
d'Avignon, A.,
and Heinecke, J. W.
(1998)
Biochemistry
37,
6864-6873[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Hazen, S. L.,
d'Avignon, A.,
Anderson, M. M.,
Hsu, F. F.,
and Heinecke, J. W.
(1998)
J. Biol. Chem.
273,
4997-5005[Abstract/Free Full Text]
|
| 35.
|
Schraufstätter, I. U.,
Hyslop, P. A.,
Hinshaw, D. B.,
Spragg, R. G.,
Sklar, L. A.,
and Cochrane, C. G.
(1986)
Proc. Natl. Acad. Sci. U. S. A.
83,
4908-4912[Abstract/Free Full Text]
|
| 36.
|
Foote, C. S.,
Goyne, T. E.,
and Lehrer, R. I.
(1983)
Nature
301,
715-716[CrossRef][Medline]
[Order article via Infotrieve]
|
| 37.
|
Lampert, M. B.,
and Weiss, S. J.
(1983)
Blood
62,
645-651[Abstract/Free Full Text]
|
| 38.
|
Thomas, E. L.,
Grisham, M. B.,
Melton, D. F.,
and Jefferson, M. M.
(1985)
J. Biol. Chem.
260,
3321-3329[Abstract/Free Full Text]
|
| 39.
|
Vile, G. F.,
Rothwell, L. A.,
and Kettle, A. J.
(2000)
Arch. Biochem. Biophys.
377,
122-128[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
Grisham, M. B.,
Jefferson, M. M.,
Melton, D. F.,
and Thomas, E. L.
(1984)
J. Biol. Chem.
259,
10404-10413[Abstract/Free Full Text]
|
| 41.
|
Test, S. T.,
and Weiss, S. J.
(1986)
Adv. Free Radic. Biol. Med.
2,
91-116
|
| 42.
|
Dallegri, F.,
Ballestrero, A.,
Frumento, G.,
and Patrone, F.
(1986)
J. Clin. Lab. Immunol.
20,
37-41[Medline]
[Order article via Infotrieve]
|
| 43.
|
Cantin, A. M.
(1994)
J. Clin. Invest.
93,
606-614[Medline]
[Order article via Infotrieve]
|
| 44.
|
Nagl, M.,
Hess, M. W.,
Pfaller, K.,
Hengster, P.,
and Gottardi, W.
(2000)
Antimicrob. Agents Chemother.
44,
2507-2513[Abstract/Free Full Text]
|
| 45.
|
Weiss, S. J.,
Lampert, M. B.,
and Test, S. T.
(1983)
Science
222,
625-628[Abstract/Free Full Text]
|
| 46.
|
Wright, C. E.,
Harris, H. H.,
and Lin, Y. Y.
(1986)
Annu. Rev. Biochem.
55,
427-453[CrossRef][Medline]
[Order article via Infotrieve]
|
| 47.
|
Monnier, V. M.,
Sell, D. R.,
Nagaraj, R. H.,
and Miyata, S.
(1991)
Gerontology
37,
152-165[Medline]
[Order article via Infotrieve]
|
| 48.
|
Learn, D. B.,
Fried, V. A.,
and Thomas, E. L.
(1990)
J. Leukocyte Biol.
48,
174-182[Abstract]
|
| 49.
|
Wagner, B. A.,
Buettner, G. R.,
Oberley, L. W.,
Darby, C. J.,
and Burns, C. P.
(2000)
J. Biol. Chem.
275,
22461-22469[Abstract/Free Full Text]
|
| 50.
|
Zgliczynski, J. M.,
Stelmaszynska, T.,
Domanski, J.,
and Ostrowski, W.
(1971)
Biochim. Biophys. Acta
235,
419-424[Medline]
[Order article via Infotrieve]
|
| 51.
|
Anderson, M. M.,
Hazen, S. L.,
Hsu, F. F.,
and Heinecke, J. W.
(1997)
J. Clin. Invest.
99,
424-432[Medline]
[Order article via Infotrieve]
|
| 52.
|
van den Berg, J. J.,
Winterbourn, C. C.,
and Kuypers, F. A.
(1993)
J. Lipid Res.
34,
2005-2012[Abstract]
|
| 53.
|
Heinecke, J. W., Li, W.,
Mueller, D. M.,
Bohrer, A.,
and Turk, J.
(1994)
Biochemistry
33,
10127-10136[CrossRef][Medline]
[Order article via Infotrieve]
|
| 54.
|
Carr, A. C.,
van den Berg, J. J. M.,
and Winterbourn, C. C.
(1996)
Arch. Biochem. Biophys.
332,
63-69[CrossRef][Medline]
[Order article via Infotrieve]
|
| 55.
|
Peskin, A. V.,
and Winterbourn, C. C.
(2001)
Free Radic. Biol. Med.
30,
572-579[CrossRef][Medline]
[Order article via Infotrieve]
|
| 56.
|
Carr, A. C.,
Hawkins, C. L.,
Thomas, S. R.,
Stocker, R.,
and Frei, B.
(2001)
Free Radic. Biol. Med.
30,
526-536[CrossRef][Medline]
[Order article via Infotrieve]
|
| 57.
|
Maier, K. L.,
Matejkova, E.,
Hinze, H.,
Leuschel, L.,
Weber, H.,
and Beck-Speier, I.
(1989)
FEBS Lett.
250,
221-226[CrossRef][Medline]
[Order article via Infotrieve]
|
| 58.
|
Davies, J. M.,
Horwitz, D. A.,
and Davies, K. J.
(1994)
Arthritis Rheum.
37,
424-427[Medline]
[Order article via Infotrieve]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us 